Stockscreener 앱 받기
33.02
2.71%
0.87
시간 외 거래:
33.02
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
What indicators show strength in Vaxcyte Inc.Weekly Investment Summary & Growth Oriented Trade Recommendations - Newser
What are Vaxcyte Inc.’s growth leversRate Hike & Daily Profit Maximizing Tips - خودرو بانک
What are Vaxcyte Inc.’s recent SEC filings showingNew Guidance & Daily Chart Pattern Signal Reports - خودرو بانک
Vaxcyte, Inc. shares rise 3.73% intraday after presenting at Cantor Global Healthcare Conference. - AInvest
Vaxcyte Inc. stock outlook for YEARJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
Short interest data insights for Vaxcyte Inc.2025 Momentum Check & Fast Moving Stock Watchlists - Newser
Vaxcyte Inc. stock trend forecastGold Moves & Free Safe Entry Trade Signal Reports - Newser
Is Vaxcyte Inc. forming a bottoming base2025 Key Highlights & Risk Controlled Stock Alerts - Newser
Will Vaxcyte Inc. stock recover after earningsQuarterly Portfolio Report & Long-Term Safe Investment Ideas - خودرو بانک
Advanced analytics toolkit walkthrough for Vaxcyte Inc.Earnings Miss & High Conviction Investment Ideas - Newser
Is Vaxcyte Inc. stock technically oversoldMarket Trend Review & Proven Capital Preservation Tips - خودرو بانک
How to forecast Vaxcyte Inc. trends using time seriesJuly 2025 Summary & Daily Price Action Insights - Newser
Multi factor analysis applied to Vaxcyte Inc.2025 Earnings Impact & Weekly Market Pulse Updates - Newser
How to interpret RSI for Vaxcyte Inc. stockJuly 2025 Catalysts & Consistent Income Trade Recommendations - Newser
Live market analysis of Vaxcyte Inc.Weekly Profit Report & Safe Entry Point Identification - Newser
Is Vaxcyte Inc. forming a reversal patternJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Visualizing Vaxcyte Inc. stock with heatmapsEarnings Miss & Advanced Swing Trade Entry Alerts - Newser
Analyzing Vaxcyte Inc. with risk reward ratio charts2025 Support & Resistance & Safe Swing Trade Setups - Newser
Vaxcyte shares rise 1.90% after-hours as VAX-31 Phase 2 study advances to final stage. - AInvest
Vaxcyte Says VAX-31 Pneumococcal Disease Study Advances to Final Stage - MarketScreener
Vaxcyte advances VAX-31 pneumococcal vaccine to final stage of infant study - Investing.com
Vaxcyte Advances VAX-31 Infant Phase 2 Study with New Optimized Dose Aimed at Enhancing Immune Response Against Invasive Pneumococcal Disease - Quiver Quantitative
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose - GlobeNewswire
92% Disease Coverage: Vaxcyte's VAX-31 Could Become Broadest Pneumococcal Vaccine for Infants - Stock Titan
What recovery options are there for Vaxcyte Inc.2025 Top Gainers & High Conviction Investment Ideas - Newser
How to build a custom watchlist for Vaxcyte Inc.July 2025 Update & Community Supported Trade Ideas - Newser
Evaluating Vaxcyte Inc. with trendline analysisWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
How institutional ownership impacts Vaxcyte Inc. stockMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
What is the target price for Vaxcyte Inc. stock2025 Trading Volume Trends & Trade Opportunity Analysis Reports - khodrobank.com
Can Vaxcyte Inc. expand its profit marginsQuarterly Earnings Report & Daily Technical Forecast Reports - خودرو بانک
How to manage a losing position in Vaxcyte Inc.July 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Is Vaxcyte Inc. stock good for income investorsWeekly Earnings Recap & Weekly Momentum Picks - خودرو بانک
Market Wrap: Can Vaxcyte Inc. expand its profit marginsPortfolio Risk Report & Reliable Trade Execution Plans - خودرو بانک
Is Vaxcyte Inc. in a bullish channelQuarterly Portfolio Review & Safe Capital Growth Tips - خودرو بانک
Is Vaxcyte Inc. stock reversal real or fakeTrade Analysis Summary & Weekly Market Pulse Updates - Newser
Insider Sell: What is the PEG ratio of Vaxcyte Inc.July 2025 Spike Watch & Consistent Return Investment Signals - خودرو بانک
What is the long term forecast for Vaxcyte Inc. stock2025 Sector Review & Growth Focused Investment Plans - خودرو بانک
Risk vs reward if holding onto Vaxcyte Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - Newser
InvestingPro’s Fair Value model predicted Vaxcyte’s 46% decline By Investing.com - Investing.com
Full technical analysis of Vaxcyte Inc. stockTrade Risk Summary & Reliable Entry Point Trade Alerts - Newser
Market Outlook: How does Vaxcyte Inc. compare to its peersQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - خودرو بانک
Momentum Shift: What are Vaxcyte Inc.’s recent SEC filings showing2025 Big Picture & Low Drawdown Trading Strategies - خودرو بانک
Is Vaxcyte Inc. vulnerable to short sellersTrade Volume Summary & Low Drawdown Investment Strategies - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):